Sua seleção (0)
Detalhe da pesquisa
1.
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.
Circulation;
140(23): 1895-1903, 2019 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553222
2.
Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials.
Circulation;
137(5): 464-479, 2018 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29089314
3.
Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial.
Lancet;
392(10157): 1530-1540, 2018 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266412
4.
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.
N Engl J Med;
374(17): 1609-20, 2016 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27040324
5.
The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale.
Am Heart J;
216: 82-90, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31415994
6.
Intravascular lithotripsy-assisted Impella insertion: A case report.
Catheter Cardiovasc Interv;
93(7): 1317-1319, 2019 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811781
7.
A CHIP fellow's transition into practice: Building a complex coronary therapeutics program.
Catheter Cardiovasc Interv;
2019 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31763767
8.
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.
Circ Res;
120(2): 324-331, 2017 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821724
9.
Changes in mechanical dyssynchrony in severe aortic stenosis patients undergoing transcatheter aortic valve replacement.
Echocardiography;
36(2): 243-248, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623480
10.
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.
Eur Heart J;
39(23): 2208-2216, 2018 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315376
11.
Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).
Circulation;
135(18): 1720-1732, 2017 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28228427
12.
2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy.
Lancet;
390(10096): 760-772, 2017 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28732815
13.
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.
N Engl J Med;
373(20): 1905-15, 2015 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26457558
14.
Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention.
Am Heart J;
205: 110-117, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30218844
15.
Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.
Catheter Cardiovasc Interv;
2018 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393942
16.
Effect of transcatheter aortic valve replacement on left atrial function.
Echocardiography;
35(11): 1713-1720, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30079522
17.
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial.
JAMA;
319(1): 27-37, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29297076
18.
Bioresorbable Vascular Scaffolds for Coronary Revascularization.
Circulation;
134(2): 168-82, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27400899
19.
Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
Circulation;
134(14): 989-998, 2016 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27576774
20.
Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.
Circulation;
133(18): 1772-82, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26994121